BRIEF published on 07/24/2026 at 07:05, 3 months 19 days ago BB Biotech AG annonce des résultats intermédiaires et ajuste sa politique de dividendes. Politique De Dividendes Portefeuille D'investissement BB Biotech Rapport Intérimaire Gain Net
BRIEF published on 07/24/2026 at 07:05, 3 months 19 days ago BB Biotech T2 2026 : Forte performance de l’actif net grâce à des investissements stratégiques Investissements Stratégiques Politique De Dividendes Diversification Du Portefeuille Activité De Fusions Et Acquisitions Performance En Biotechnologie
BRIEF published on 07/24/2026 at 07:05, 3 months 19 days ago BB Biotech Q2 2026: Robust NAV Performance Amid Strategic Investments Portfolio Diversification Dividend Policy Strategic Investments M&A Activity Biotechnology Performance
PRESS RELEASE published on 07/24/2026 at 07:00, 3 months 19 days ago EQS-Adhoc: BB Biotech AG publishes its interim report and revises its dividend policy BB Biotech AG publishes its interim report for the first half of 2026, reporting a net gain and revising its dividend policy. Details at www.bbbiotech.ch Financial Results Investment Company Dividend Policy BB Biotech AG Interim Report
PRESS RELEASE published on 07/24/2026 at 07:00, 3 months 19 days ago BB Biotech Q2 2026: Strong NAV outperformance driven by disciplined stock selection and portfolio positioning BB Biotech AG reports strong NAV outperformance in Q2 2026, driven by disciplined stock selection and portfolio positioning, new investments, and revised dividend policy Dividend Policy BB Biotech AG Stock Selection Q2 2026 NAV Outperformance
BRIEF published on 04/24/2026 at 07:05, 6 months 18 days ago BB Biotech AG Reports Q1 2026 Interim Results Drug Development Net Loss Investment Portfolio BB Biotech Q1 2026
BRIEF published on 04/24/2026 at 07:05, 6 months 18 days ago BB Biotech AG publie ses résultats intermédiaires du premier trimestre 2026 Perte Nette Portefeuille D'investissement Développement De Médicaments BB Biotech 1er Trimestre 2026
BRIEF published on 04/24/2026 at 07:05, 6 months 18 days ago BB Biotech Q1 2026 Achievements and Strategic Shifts Net Asset Value Portfolio Repositioning New Investments BB Biotech Performance Dividend Inclusion
BRIEF published on 04/24/2026 at 07:05, 6 months 18 days ago Réalisations et évolutions stratégiques de BB Biotech au premier trimestre 2026 Valeur Nette D'actif Nouveaux Investissements Performance De BB Biotech Repositionnement De Portefeuille Inclusion De Dividendes
PRESS RELEASE published on 04/24/2026 at 07:00, 6 months 18 days ago EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes its interim report for the first quarter of 2026, showing a net loss of CHF 21 mn compared to CHF 241 mn in the same period of 2025 Investment Company BB Biotech AG Interim Report Results Loss
Published on 11/13/2026 at 02:40, 1 hour 40 minutes ago Jaguar Mining Reports Third Quarter 2026 Results with 67% Growth in Adjusted Net Income and 46% Higher Adjusted EBITDA
Published on 11/13/2026 at 02:10, 2 hours 10 minutes ago Amarc to Participate in Consolidation of Aurora West Through Aurora Minerals LTD
Published on 11/12/2026 at 23:25, 4 hours 55 minutes ago Renegade Gold Announces Bought Deal Private Placement for Gross Proceeds of C$5 Million
Published on 11/12/2026 at 23:05, 5 hours 15 minutes ago Caldwell Reports Fourth Quarter and Full Year Fiscal 2026 Results; Increases Quarterly Dividend and Declares a Special Dividend
Published on 11/12/2026 at 23:00, 5 hours 20 minutes ago Redwood AI Announces Chemical Risk Analysis Update to its AI-Powered Reactosphere Platform to Support Faster Reaction Safety Screening
Published on 11/12/2026 at 23:10, 5 hours 9 minutes ago DeFi Technologies Inc. Announces Third Quarter 2026 Financial Results with Revenue of $18.3 Million, Operating Income of $7.0 Million, and Net Income of $22.3 Million
Published on 11/12/2026 at 22:35, 5 hours 44 minutes ago Silverfort Named a Leader in the IDC MarketScape for Worldwide Augmented Identity Security Solutions 2026 Vendor Assessment
Published on 11/12/2026 at 19:50, 8 hours 30 minutes ago Eurobattery Minerals receives shareholder requests for additional items on the agenda of the upcoming Extraordinary General Meeting
Published on 11/12/2026 at 18:25, 9 hours 54 minutes ago OMAN AWARDS TWO GREEN HYDROGEN PROJECTS IN DUQM AND LAUNCHES ROUND 4 GREEN-POWERED DATA CENTRE HYDROGEN AUCTION AT COP31
Published on 11/12/2026 at 18:14, 10 hours 6 minutes ago EQS-Adhoc: HUGO BOSS AG: Daniel Grieder to step down as CEO of HUGO BOSS effective December 31, 2026 - David Epstein appointed as CEO effective January 1, 2027
Published on 11/12/2026 at 23:12, 5 hours 7 minutes ago Belgrano continues the implementation of its public share buyback offer (OPRA)
Published on 11/12/2026 at 23:12, 5 hours 7 minutes ago Belgrano poursuit la mise en oeuvre de son projet d'OPRA
Published on 11/12/2026 at 23:00, 5 hours 20 minutes ago Assemblée générale du 12 novembre 2026 : quorum non atteint - Convocation d’une seconde assemblée générale le 27 novembre 2026
Published on 11/12/2026 at 18:36, 9 hours 43 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/10/2026
Published on 11/12/2026 at 18:36, 9 hours 43 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/10/2026
